Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity-Reference-Cited by-同舟云学术

Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity

Published:2020-07 Issue:4 Volume:19 Page:632-640
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Sagel Scott D.^ORCID,Wagner Brandie D.,Ziady Assem,Kelley Tom,Clancy John P.,Narvaez-Rivas Monica,Pilewski Joseph,Joseloff Elizabeth,Sha Wei,Zelnick Leila,Setchell Kenneth D.R.,Heltshe Sonya L.^ORCID,Muhlebach Marianne S.^ORCID

Funder

Cystic Fibrosis Foundation Therapeutics

NIH/NCATS Colorado

NIH/NIDDK

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference43 articles.

1. Biomarkers for cystic fibrosis drug development;Muhlebach;J Cyst Fibros,2016

2. Take it to the bank;Clancy;J Cyst Fibros,2017

3. The cystic fibrosis foundation patient registry. design and methods of a national observational disease registry;Knapp;Ann Am Thorac Soc,2016

4. Effect of azithromycin on systemic markers of inflammation in cystic fibrosis patients uninfected with pseudomonas aeruginosa;Ratjen;Chest,2012

5. Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation;Sagel;Ann Am Thorac Soc,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in fecal lipidome after treatment with ivacaftor without changes in microbiome or bile acids;Journal of Cystic Fibrosis;2023-10

2. Essential Fatty Acid Deficiency Associates with Growth Faltering and Environmental Enteric Dysfunction in Children;Metabolites;2023-03-29

3. Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D;Journal of Cystic Fibrosis;2022-11

4. Club cell secretory protein and lung function in children with cystic fibrosis;Journal of Cystic Fibrosis;2022-09

5. Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis;Bratislava Medical Journal;2022